Pre-exposure prophylaxis access in federally qualified health centers across 11 United States metropolitan statistical areas

被引:11
作者
Tookes, Hansel [1 ]
Yao, Kristiana [1 ]
Chueng, Teresa [1 ]
Butts, Stefani [1 ]
Karsner, Ryan [1 ]
Duque, Maria [1 ]
Cardenas, Gabriel [2 ]
Feaster, Daniel J. [2 ]
Doblecki-Lewis, Susanne [1 ]
机构
[1] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA
关键词
Pre-exposure prophylaxis; HIV; prevention; federally qualified health centers; men who have sex with men; public health; WAIT-TIMES; HIV; POSTEXPOSURE; PREP; MEN; GAY;
D O I
10.1177/0956462419855178
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pre-exposure prophylaxis (PrEP) is a promising tool for HIV prevention, but uptake has been slow in key demographics and geographic areas including racial and ethnic minorities. Federally qualified health centers (FQHCs), serving those with heightened risk of contracting HIV, including low-income and minority patients regardless of ability to pay, are potential sites for PrEP delivery. This study aims to determine availability of PrEP at FQHCs in the US. FQHCs in the 11 largest U.S. metropolitan statistical areas (MSAs) were included. The south included Atlanta, Dallas, District of Columbia, Houston, and Miami. Reference MSAs included Boston, Chicago, Los Angeles, New York, Philadelphia, and San Francisco. We randomly selected 360 FQHCs for phone calls in which investigators queried the availability of PrEP for HIV prevention at each center. The study was powered to determine a 10% difference in proportion of clinics with PrEP services by region. We used a bivariate logistic regression to compare cities and regions. The percentage of FQHCs providing PrEP generally was low within this sample, with 0-28.0% offering PrEP services in the southern and 14.0-33.3% in reference metropolitan areas. Overall, 19.3% of clinics sampled indicated that they offered PrEP. Logistic regression did not show any difference between southern and reference regions (p = 0.779). However, the total number of FQHCs was significantly lower in southern metropolitan areas (p = 0.014). FQHCs in all metropolitan areas provided limited access to PrEP. Interventions, including technical assistance to increase PrEP availability in these settings catering to underserved populations, could be beneficial.
引用
收藏
页码:978 / 984
页数:7
相关论文
共 16 条
  • [11] Short wait times for patients seeking cosmetic botulinum toxin appointments with dermatologists
    Resneck, Jack S., Jr.
    Lipton, Shira
    Pletcher, Mark J.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (06) : 985 - 989
  • [12] Preexposure Prophylaxis Initiation and Retention in Care Over 5 Years, 2012-2017: Are Quarterly Visits Too Much?
    Rusie, Laura K.
    Orengo, Carlos
    Burrell, Diane
    Ramachandran, Arthi
    Houlberg, Magda
    Keglovitz, Kristin
    Munar, David
    Schneider, John A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 67 (02) : 283 - 287
  • [13] HIV Preexposure Prophylaxis Initiation at a Large Community Clinic: Differences Between Eligibility, Awareness, and Uptake
    Shover, Chelsea L.
    Javanbakht, Marjan
    Shoptaw, Steven
    Bolan, Robert K.
    Lee, Sung-Jae
    Parsons, Jeffrey T.
    Rendina, Jonathon
    Gorbach, Pamina M.
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2018, 108 (10) : 1408 - 1417
  • [14] Even patients with changing moles face long dermatology appointment wait-times: A study of simulated patient calls to dermatologists
    Tsang, Matthew W.
    Resneck, Jack S., Jr.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (01) : 54 - 58
  • [15] Weiss K, 2018, C RETR OPP INF BOST
  • [16] Australian Gay Men Who Have Taken Nonoccupational Postexposure Prophylaxis for HIV Are in Need of Effective HIV Prevention Methods
    Zablotska, Iryna B.
    Prestage, Garrett
    Holt, Martin
    Poynten, Mary
    de Wit, John
    Guy, Rebecca
    Mao, Limin
    McAllister, John
    Grulich, Andrew E.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 58 (04) : 424 - 428